GentaGel

GentaGel develops a local slow-release antibiotic treatment for infection prevention and treatment.

Health Tech & Life Sciences
Active
Pre-Funding Jerusalem, Israel Founded 2021
Website ↗
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2021
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

GentaGel-LR is an Israeli startup that has developed a biodegradable gel for targeted, high-dose antibiotic delivery directly to infected sites. This local slow-release antibiotic treatment, injected and continuously releasing antibiotics for up to 60 days, aims to prevent infections where systemic antibiotics are insufficient. The technology, invented by Prof. Avi Domb, focuses on in-situ sustained release of antibiotics for treating and preventing surgical site infections, minimizing toxicity, fighting resistant bacteria, and reducing re-interventions and costs. The company is backed by FDA Fast Track and is pioneering a scalable platform for infection care. GentaGel-LR's technology is also well-suited for animal health, offering a local, long-lasting sustained release of antibiotics for livestock and pets, avoiding systemic use and providing effective treatment for over a month with a single administration.

Q&A

What is GentaGel's primary focus?
GentaGel develops a local slow-release antibiotic treatment designed to be injected and continuously release antibiotics for up to 60 days, aiming to treat and prevent surgical site infections.
When was GentaGel founded?
GentaGel was founded in July 2021.
How many employees does GentaGel currently have?
GentaGel has 6 employees, falling into the 1-10 employee bucket.
What is GentaGel's current funding stage?
GentaGel is currently in the Pre-Funding stage.
Who is a co-founder of GentaGel?
Abraham Domb is a co-founder of GentaGel and also the inventor of the drug delivery technology upon which the company is based.
What sector does GentaGel primarily operate in?
GentaGel's primary sector is Health Tech & Life Sciences, with additional classifications in Pharma & Medical Biotechnology, Drug Delivery, Medical Devices, and Medical Treatment & Therapeutics.
What is the product stage of GentaGel's treatment?
The product stage of GentaGel's treatment is clinical trial.
Where is GentaGel headquartered?
GentaGel is headquartered in Jerusalem, Israel.

Team · 1

Prof. Avi Domb
Founder · Inventor and Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesPolymers
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProvidersMedical Devices IndustryMedical Products
Business model
B2C

Tags

polymersantibioticspharmaceuticalsinfection
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitegentagel-lr.com/

Identifiers & details

Legal nameGENTAGEL- LR LTD
Founded2021-7
Employees (exact)6

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domaingentagel-lr.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516427762
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-07-05
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2024
Active charges / liens0
Registry events0
Registered addressהכלנית 10 ירושלים